These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 32087614)

  • 1. Renal expression and urinary excretion of liver-type fatty acid-binding protein in cats with renal disease.
    Katayama M; Ohata K; Miyazaki T; Katayama R; Wakamatsu N; Ohno M; Yamashita T; Oikawa T; Sugaya T; Miyazaki M
    J Vet Intern Med; 2020 Mar; 34(2):761-769. PubMed ID: 32087614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal changes in urinary excretion of liver-type fatty acid binding protein (L-FABP) in acute kidney injury model of domestic cats: a preliminary study.
    Katayama M; Miyazaki T; Ohata K; Oikawa T; Kamiie J; Sugaya T; Miyazaki M
    J Vet Med Sci; 2019 Dec; 81(12):1868-1872. PubMed ID: 31645505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary study of urinary excretion of liver-type fatty acid-binding protein in a cat model of chronic kidney disease.
    Watanabe A; Ohata K; Oikawa T; Sugaya T; Miyazaki M; Satoh H; Katayama M
    Can J Vet Res; 2021 Apr; 85(2):156-160. PubMed ID: 33883825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary liver-type fatty acid-binding protein in clinically healthy elderly cats: Evaluation of its potential to detect IRIS stage 1 chronic kidney disease and borderline proteinuria.
    Kongtasai T; Paepe D; Mortier F; Marynissen S; Meyer E; Duchateau L; Daminet S
    Vet Med Sci; 2023 Jan; 9(1):3-12. PubMed ID: 36418182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of urinary liver-type fatty acid-binding protein for the diagnosis of renal diseases in dogs.
    Takashima S; Nagamori Y; Ohata K; Oikawa T; Sugaya T; Kobatake Y; Nishii N
    J Vet Med Sci; 2021 Sep; 83(9):1465-1471. PubMed ID: 34526412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver-type fatty acid-binding protein and neutrophil gelatinase-associated lipocalin in cats with chronic kidney disease and hyperthyroidism.
    Kongtasai T; Meyer E; Paepe D; Marynissen S; Smets P; Mortier F; Demeyere K; Vandermeulen E; Stock E; Buresova E; Defauw P; Duchateau L; Daminet S
    J Vet Intern Med; 2021 May; 35(3):1376-1388. PubMed ID: 33723886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of urinary liver-type fatty acid-binding protein to contrast media administration has a potential to predict one-year renal outcome in patients with ischemic heart disease.
    Fujita D; Takahashi M; Doi K; Abe M; Tazaki J; Kiyosue A; Myojo M; Ando J; Fujita H; Noiri E; Sugaya T; Hirata Y; Komuro I
    Heart Vessels; 2015 May; 30(3):296-303. PubMed ID: 24554034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary liver-type fatty acid-binding protein in pediatric nephrotic syndrome and tubular dysfunction.
    Nishida M; Kawakatsu H; Hamaoka K
    Pediatr Int; 2018 May; 60(5):442-445. PubMed ID: 29460503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [L-type fatty acid binding protein (L-FABP) and kidney disease].
    Kamijo-Ikemori A; Sugaya T; Kimura K
    Rinsho Byori; 2014 Feb; 62(2):163-70. PubMed ID: 24800492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of a urinary biomarker panel for obstructive nephropathy and clinical outcomes.
    Xie Y; Xue W; Shao X; Che X; Xu W; Ni Z; Mou S
    PLoS One; 2014; 9(11):e112865. PubMed ID: 25402279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.
    Nakamura T; Sugaya T; Kawagoe Y; Ueda Y; Osada S; Koide H
    Diabetes Care; 2005 Nov; 28(11):2728-32. PubMed ID: 16249547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary NGAL, KIM-1 and L-FABP concentrations in antenatal hydronephrosis.
    Noyan A; Parmaksiz G; Dursun H; Ezer SS; Anarat R; Cengiz N
    J Pediatr Urol; 2015 Oct; 11(5):249.e1-6. PubMed ID: 26096437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Urinary Liver-Type Fatty Acid-Binding Protein Level Predicts Worsening Renal Function in Patients With Acute Heart Failure.
    Okubo Y; Sairaku A; Morishima N; Ogi H; Matsumoto T; Kinoshita H; Kihara Y
    J Card Fail; 2018 Aug; 24(8):520-524. PubMed ID: 30026130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of liver-type fatty acid-binding protein as a marker of progressive kidney function deterioration in patients with chronic glomerulonephritis.
    Mou S; Wang Q; Li J; Shi B; Ni Z
    Clin Chim Acta; 2012 Jan; 413(1-2):187-91. PubMed ID: 21958699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Urinary L-type fatty acid binding protein (L-FABP) as a new urinary biomarker promulgated by the Ministry of Health, Labour and Welfare in Japan].
    Kamijo-Ikemori A; Ichikawa D; Matsui K; Yokoyama T; Sugaya T; Kimura K
    Rinsho Byori; 2013 Jul; 61(7):635-40. PubMed ID: 24205707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy.
    Hofstra JM; Deegens JK; Steenbergen EJ; Wetzels JF
    Nephrol Dial Transplant; 2008 Oct; 23(10):3160-5. PubMed ID: 18403431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary Liver-Type Fatty Acid-Binding Protein Predicts Residual Renal Function Decline in Patients on Peritoneal Dialysis.
    Torigoe K; Muta K; Tsuji K; Yamashita A; Ota Y; Kitamura M; Mukae H; Nishino T
    Med Sci Monit; 2020 Dec; 26():e928236. PubMed ID: 33347426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary liver-type fatty acid-binding protein levels for differential diagnosis of idiopathic focal glomerulosclerosis and minor glomerular abnormalities and effect of low-density lipoprotein apheresis.
    Nakamura T; Sugaya T; Kawagoe Y; Ueda Y; Osada S; Koide H
    Clin Nephrol; 2006 Jan; 65(1):1-6. PubMed ID: 16429835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease.
    Kamijo A; Sugaya T; Hikawa A; Yamanouchi M; Hirata Y; Ishimitsu T; Numabe A; Takagi M; Hayakawa H; Tabei F; Sugimoto T; Mise N; Omata M; Kimura K
    Mol Cell Biochem; 2006 Mar; 284(1-2):175-82. PubMed ID: 16532260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary fatty acid binding protein as a new clinical marker for the progression of chronic renal disease].
    Kamijo A; Sugaya T; Hikawa A; Kimura K
    Rinsho Byori; 2003 Mar; 51(3):219-24. PubMed ID: 12707994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.